SCHEMBL19746710

SCHEMBL19746710

O=c1cc(-c2noc(C(F)(F)F)n2)cnn1Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 16/20 0.53
HDAC1 Q13547 9/20 0.53
HDAC8 Q9BY41 5/20 0.53
HDAC4 P56524 10/20 0.53
HDAC3 O15379 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC9 Q9UKV0 1/20 0.46
NCOR2 Q9Y618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21478330 0.81 HDAC6 (0.50) HDAC6HDAC1HDAC8HDAC4HDAC3
SCHEMBL25124405 0.78 HDAC6 (0.60) HDAC6HDAC1HDAC8HDAC4
SCHEMBL24169032 0.77 HDAC6 (0.59) HDAC6HDAC1HDAC8HDAC4
SCHEMBL20184021 0.76 HDAC6 (0.53) HDAC6HDAC1HDAC8HDAC4HDAC5
SCHEMBL21407229 0.76 HDAC6 (0.63) HDAC6HDAC1HDAC8HDAC4
SCHEMBL29393995 0.76 HDAC6 (0.63) HDAC6HDAC1HDAC8HDAC4
SCHEMBL19746136 0.76 HDAC6 (0.57) HDAC6HDAC1HDAC8HDAC4HDAC5
SCHEMBL19746416 0.74 HDAC6 (0.65) HDAC6HDAC1HDAC8HDAC4HDAC3
SCHEMBL25124289 0.74 HTT (0.55) HDAC6HDAC1HDAC8HDAC4
SCHEMBL22074668 0.73 HDAC6 (0.57) HDAC6HDAC1HDAC8HDAC4HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017222952-A1 3- HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-12-28 WO claimed
WO-2017222952-A1 3- HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-12-28 WO disclosed